Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck
NCT01527877
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
53
Enrollment
OTHER
Sponsor class
Conditions
Head Neck Cancer Squamous Cell Metastatic
Head Neck Cancer Squamous Cell Recurrent
Interventions
DRUG:
BKM120
Sponsor
Yonsei University